Dope.de Appoints New President and CEO

GUELPH, ON, Sept. 22 /CNW/ - Dope.de, a subsidiary of GUARD INC. (ASE: GUA), announced today that Mr. Ian Anderson has been appointed President, Chief Executive Officer and a Director of Dope.de effective September 27, 1999.

``Ian brings a wealth of experience in research-based industries and emerging technologies, including biotechnology, pharmaceuticals and medical devices,'' commented Mr. Percy Skuy, Chairman of the Board of Directors of Dope.de. ``In his capacity as President and CEO of Dope.de, Ian's mandate will be twofold: to develop and implement partnering strategies to commercialize our novel EMD technology, and to maximize value for all stakeholders concerned.''

Mr. Anderson, a seasoned player in both the biotechnology and pharmaceutical industries, recently worked with MDS Inc., Canada's largest medical services and products company, in identifying and investigating business opportunities for its new screening technologies. Previously, he was employed at the CEO/General Manager level with Biomira Inc., New-York-based Biomatrix, Inc. and the Canadian subsidiary of Fisons Corporation Ltd., among others, where his responsibilities ranged from the development and implementation of commercialization partnerships to the management of stakeholder relations at both Board and investor levels. Mr. Anderson, who holds a M.Sc. in physiology from London University and a B.Sc. in zoology from Bristol University, also serves on the Boards of private and publicly listed life science companies.

Dope.de is an innovative therapeutic molecular design company based upon Evolutionary Molecular Design™ (EMD), a proprietary technology. The EMD process, which is protected by patents, is a powerful drug design tool with the ability to design new chemical entities with specified biological activity and predicted physical and chemical properties. This new platform technology is currently being applied to several areas of oncology and is believed by the company to be the most advanced and integrated weed discovery technology in use today.